We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Respiratory Syncytial Virus (RSV) Vaccine
From 1 September 2024, those who turn 75 and those age 75 to 79 will be eligible for a free vaccine to protect them from respiratory syncytial virus (RSV). Patients will be contacted by text message and telephone to book an appointment.
RSV is an infectious disease of the airways and lungs. RSV infection often causes symptoms similar to a cold, including:
- cough
- sore throat
- sneezing
- a runny or blocked nose
It can also make you become wheezy or short of breath and lead to pneumonia and other life-threatening conditions. There is no specific treatment, and most infections will get better by themselves. Every year thousands of older adults need hospital care for RSV, and some of them will die. RSV can be more severe in people with medical conditions such as heart or lung disease or a weakened immune system.
RSV infection is common in young children but is most serious for small babies and for older people.
Your guide to the RSV vaccine for older adults
Published: Aug 20, 2024
